Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 7 (10) , 665-70
Abstract
Myocardial infarction is the most common cause of congestive heart failure. Novel strategies such as directly reprogramming cardiac fibroblasts into cardiomyocytes are an exciting area of investigation for repair of injured myocardial tissue. The ultimate goal is to rebuild functional myocardium by transplanting exogenous stem cells or by activating native stem cells to induce endogenous repair. Cell-based myocardial restoration, however, has not penetrated broad clinical practice yet. Platelet-rich plasma, an autologous fractionation of whole blood containing high concentrations of growth factors, has been shown to safely and effectively enhance healing and angiogenesis primarily by reparative cell signaling. In this review, we collected all recent advances in novel therapies as well as experimental evidence demonstrating the role of platelet-rich plasma in ischemic heart disease, focusing on aspects that might be important for future successful clinical application.Keywords
This publication has 43 references indexed in Scilit:
- Strategies for Heart RegenerationInternational Heart Journal, 2015
- Therapeutic Application of Adipose Derived Stem Cells in Acute Myocardial Infarction: Lessons from Animal ModelsStem Cell Reviews and Reports, 2014
- Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or AgentsAngewandte Chemie International Edition, 2014
- The Effect of Autologous Platelet-Rich Plasma on Bronchial Stump Tissue Granulation after Pneumonectomy: Experimental StudyISRN Surgery, 2013
- Efecto del plasma autógeno rico en plaquetas sobre el infarto de miocardio en ovejasArchivos de Cardiología de México, 2013
- Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesEuropean Heart Journal, 2011
- PDGF and Vessel Maturation2009
- Angiogenic properties of sustained release platelet-rich plasma: Characterization in-vitro and in the ischemic hind limb of the mouseJournal of Vascular Surgery, 2009
- Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGFThe Annals of Thoracic Surgery, 2004
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997